Literature DB >> 12098569

Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis.

Bruno Marchand1, Philippe C Douek, Philippe Robert, Claire Corot, Jean Pierre Roux, Patrice Adeleine, Marcela Hernandez-Hoyos, Yannick Cremillieux, Maciej Orkisz, Emmanuelle Canet.   

Abstract

PURPOSE: To investigate the relative role of high resolution (spatial or temporal) magnetic resonance angiography (MRA) sequence and of contrast agent properties in the evaluation of high-degree arterial stenosis.
METHODS: We qualitatively and quantitatively studied both 50 and 95% (300 microm diameter) stenosis of a 6 mm arterial phantom with two contrast agents (CA), Gd-DOTA (r(1)=2.9 mM(-1) s(-1)) versus P760 (r(1)=25 mM(-1) s(-1)) at several CA concentrations, including arterial peak concentration after injection of either a single or double dose of CA, using either a high temporal (booster) or high spatial (HR) resolution 3D MRA sequences. Experimental data were then compared to theoretical data.
RESULTS: With the 3D HR sequence, both visual and quantitative analysis were significantly better compared to the 3D booster sequence, at each phantom diameter. Quantitative analysis was significantly improved by injection of a double versus a single dose of each CA (Gd-DOTA or P760), primarily in high degree stenosis.
CONCLUSION: Combined MRA spatial resolution and high CA efficiency are mandatory to correctly evaluate high degree stenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098569     DOI: 10.1007/BF02668220

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.533


  42 in total

1.  P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties.

Authors:  M Port; D Meyer; B Bonnemain; C Corot; M Schaefer; O Rousseaux; C Simonot; P Bourrinet; S Benderbous; A Dencausse; L Devoldere
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

Review 2.  Contrast-enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies: a review.

Authors:  M Boos; M Lentschig; K Scheffler; G M Bongartz; W Steinbrich
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

3.  Enhancement of phase-contrast MR angiography with superparamagnetic iron oxide.

Authors:  A Tanimoto; Y Yuasa; K Hiramatsu
Journal:  J Magn Reson Imaging       Date:  1998 Mar-Apr       Impact factor: 4.813

4.  MS-325: albumin-targeted contrast agent for MR angiography.

Authors:  R B Lauffer; D J Parmelee; S U Dunham; H S Ouellet; R P Dolan; S Witte; T J McMurry; R C Walovitch
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

5.  Physical, chemical, and biological evaluations of P760: a new gadolinium complex characterized by a low rate of interstitial diffusion.

Authors:  C Corot; M Port; I Raynal; A Dencausse; M Schaefer; O Rousseaux; C Simonot; L Devoldere; J Lin; M Foulon; P Bourrinet; B Bonnemain; D Meyer
Journal:  J Magn Reson Imaging       Date:  2000-02       Impact factor: 4.813

6.  Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US--a meta-analysis.

Authors:  K Visser; M G Hunink
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

7.  Effect of gadolinium on phase-contrast MR angiography of the renal arteries.

Authors:  J C Bass; M R Prince; F J Londy; T L Chenevert
Journal:  AJR Am J Roentgenol       Date:  1997-01       Impact factor: 3.959

8.  Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: value of bolus-enhanced, whole-volume subtraction technique.

Authors:  P C Douek; D Revel; S Chazel; B Falise; J Villard; M Amiel
Journal:  AJR Am J Roentgenol       Date:  1995-08       Impact factor: 3.959

9.  Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography?

Authors:  M R Patel; K M Kuntz; R A Klufas; D Kim; J Kramer; J F Polak; J J Skillman; A D Whittemore; R R Edelman; K C Kent
Journal:  Stroke       Date:  1995-10       Impact factor: 7.914

10.  In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging.

Authors:  G Schuhmann-Giampieri; H Schmitt-Willich; T Frenzel; W R Press; H J Weinmann
Journal:  Invest Radiol       Date:  1991-11       Impact factor: 6.016

View more
  1 in total

1.  Effects of image homogeneity on stenosis visualization at 7 T in a coronary artery phantom study: With and without B1-shimming and parallel transmission.

Authors:  Stefan Herz; Maria R Stefanescu; David Lohr; Patrick Vogel; Aleksander Kosmala; Maxim Terekhov; Andreas M Weng; Jan-Peter Grunz; Thorsten A Bley; Laura M Schreiber
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.